Impact of peritoneal reconfiguration on lymphocele formation after robot-assisted radical prostatectomy with pelvic lymph node dissection: a systematic review and meta-analysis of randomized controlled trials
Background Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associa...
Saved in:
Published in | Prostate cancer and prostatic diseases Vol. 27; no. 4; pp. 635 - 644 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.12.2024
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND.
Methods
A comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis.
Results
Eleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27–1.37, I
2
= 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI −0.41–0.84, I
2
= 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04–0.67, I
2
= 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21–1.0, I
2
= 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29–1.67, I
2
= 0%) were significantly lower after PF.
Conclusions
PF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events. |
---|---|
AbstractList | Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND.BACKGROUNDDifferent strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND.A comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis.METHODSA comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis.Eleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27-1.37, I2 = 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI -0.41-0.84, I2 = 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04-0.67, I2 = 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21-1.0, I2 = 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29-1.67, I2 = 0%) were significantly lower after PF.RESULTSEleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27-1.37, I2 = 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI -0.41-0.84, I2 = 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04-0.67, I2 = 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21-1.0, I2 = 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29-1.67, I2 = 0%) were significantly lower after PF.PF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events.CONCLUSIONSPF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events. BackgroundDifferent strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND.MethodsA comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis.ResultsEleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27–1.37, I2 = 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI −0.41–0.84, I2 = 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04–0.67, I2 = 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21–1.0, I2 = 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29–1.67, I2 = 0%) were significantly lower after PF.ConclusionsPF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events. Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND. A comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis. Eleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27-1.37, I = 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI -0.41-0.84, I = 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04-0.67, I = 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21-1.0, I = 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29-1.67, I = 0%) were significantly lower after PF. PF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events. Background Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND. Methods A comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis. Results Eleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27–1.37, I 2 = 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI −0.41–0.84, I 2 = 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04–0.67, I 2 = 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21–1.0, I 2 = 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29–1.67, I 2 = 0%) were significantly lower after PF. Conclusions PF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events. |
Author | Veccia, Alessandro Franco, Antonio Ditonno, Francesco Antonelli, Alessandro Moro, Fabrizio Dal De Sio, Marco Autorino, Riccardo Manfredi, Celeste De Nunzio, Cosimo |
Author_xml | – sequence: 1 givenname: Francesco orcidid: 0009-0005-0126-4731 surname: Ditonno fullname: Ditonno, Francesco organization: Department of Urology, Rush University Medical Center, Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata – sequence: 2 givenname: Celeste orcidid: 0000-0002-9706-8516 surname: Manfredi fullname: Manfredi, Celeste organization: Department of Urology, Rush University Medical Center, Unit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli” – sequence: 3 givenname: Antonio surname: Franco fullname: Franco, Antonio organization: Department of Urology, Rush University Medical Center, Department of Urology, Sant’Andrea Hospital, Sapienza University – sequence: 4 givenname: Alessandro orcidid: 0000-0001-5947-3206 surname: Veccia fullname: Veccia, Alessandro organization: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata – sequence: 5 givenname: Fabrizio Dal surname: Moro fullname: Moro, Fabrizio Dal organization: Department of Surgery, Oncology, and Gastroenterology, Urology Clinic, University of Padua – sequence: 6 givenname: Cosimo orcidid: 0000-0002-2190-512X surname: De Nunzio fullname: De Nunzio, Cosimo organization: Department of Urology, Sant’Andrea Hospital, Sapienza University – sequence: 7 givenname: Marco surname: De Sio fullname: De Sio, Marco organization: Unit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli” – sequence: 8 givenname: Alessandro orcidid: 0000-0002-7455-8803 surname: Antonelli fullname: Antonelli, Alessandro organization: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata – sequence: 9 givenname: Riccardo orcidid: 0000-0001-7045-7725 surname: Autorino fullname: Autorino, Riccardo email: ricautor@gmail.com organization: Department of Urology, Rush University Medical Center |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37875644$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UstqFjEUHqRiL_oCLiTgxs1orpOMOym2FgpudB0ymaRNyUzGJNPy9yl9JM_faRG6KAROOHyXcztuDuY0u6Z5T_Bngpn6UjhhPWkxZS3GkvNWvGqOCJddKzqsDuDPOtFKJehhc1zKDca4Jz1-0xwyqaToOD9q_l5Mi7EVJY8Wl0MFBxNRdjbNPlyt2dSQZgQv7qblOlkXHfIpT1ve-OoyymlItTWlhFLdiLIZgwWRJadSTXW2pmmH7kK9Bot4G-ymheY0OjSGUgABYl-RQWUHCnttCyXcBneHzDyiyVXTmtnEHTjsK82QTVO4BzOos-YUI3xrDiaWt81rD8G9e4wnze-z779Of7SXP88vTr9dtpZJUVvJsZcUU8e8GJTsOBsxtlRw4QbR2YFRz_HA5ICJIML0UvVOdYQKSngvPGUnzadNF9r8s7pS9RQKjCea2aW1aKoUkYQoQQD68Rn0Jq0Z-imageLeXUpAfXhErcPkRr3kMJm800-7AoDaABYGW7Lz2ob6sIeaTYiaYL0_C72dhYaz0A9noQVQ6TPqk_qLJLaRCoDnK5f_l_0C6x_ycM60 |
CitedBy_id | crossref_primary_10_1016_j_urology_2024_04_051 crossref_primary_10_3390_cancers16101932 crossref_primary_10_3390_cancers16112137 crossref_primary_10_1016_j_euros_2024_07_110 crossref_primary_10_1016_j_eururo_2024_09_023 crossref_primary_10_7759_cureus_77980 |
Cites_doi | 10.1016/j.urology.2015.02.034 10.56434/j.arch.esp.urol.20227505.65 10.1016/j.urology.2022.12.002 10.23736/S2724-6051.22.05160-6 10.1089/end.2019.0716 10.1038/s41391-023-00678-y 10.1016/j.urology.2009.03.011 10.1111/bju.13425 10.1186/1471-2288-14-135 10.1111/j.1464-410X.2011.10094.x 10.1016/j.eururo.2022.07.027 10.4103/iju.IJU_284_18 10.1016/j.euo.2023.07.009 10.1111/j.1464-410X.2012.11681.x 10.1016/j.urology.2017.05.031 10.1016/j.eururo.2006.08.015 10.1136/bmj.n71 10.1016/j.eururo.2016.08.006 10.1007/s11701-019-01010-4 10.1186/1471-2288-8-56 10.1111/bju.15497 10.1097/01.sla.0000133083.54934.ae 10.1111/biom.12817 10.1089/end.2020.0073 10.1097/JU.0000000000002693 10.1186/s13643-017-0644-y 10.1097/JU.0000000000002758 10.1038/s41391-022-00565-y 10.1002/sim.1186 10.3390/jcm12030791 10.5152/tud.2020.20255 10.1007/s00345-008-0327-3 10.1038/s41391-022-00635-1 10.1089/end.2010.0635 10.1136/emermed-2020-209567 10.1136/bmj.l4898 10.1111/j.1464-410X.2010.09580.x 10.1016/j.euf.2021.06.010 10.1016/j.euf.2023.07.007 10.1136/bmj.i4919 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Nature Limited 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. The Author(s), under exclusive licence to Springer Nature Limited. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature Limited 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. The Author(s), under exclusive licence to Springer Nature Limited. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TO 8FD FR3 H94 K9. M7Z P64 7X8 |
DOI | 10.1038/s41391-023-00744-5 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Oncogenes and Growth Factors Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biochemistry Abstracts 1 Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Oncogenes and Growth Factors Abstracts Technology Research Database Biochemistry Abstracts 1 AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Oncogenes and Growth Factors Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1476-5608 |
EndPage | 644 |
ExternalDocumentID | 37875644 10_1038_s41391_023_00744_5 |
Genre | Meta-Analysis Systematic Review Journal Article |
GroupedDBID | --- -Q- 0R~ 123 29P 2WC 36B 39C 4.4 406 53G 70F 7X7 88E 8AO 8C1 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAYZH ABAKF ABAWZ ABBRH ABDBE ABDBF ABFSG ABJNI ABRTQ ABUWG ABZZP ACAOD ACGFS ACIWK ACKTT ACPRK ACRQY ACSTC ACUHS ACZOJ ADBBV AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ATHPR AXYYD AYFIA B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DU5 E3Z EAD EAP EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL ESX F5P FDQFY FERAY FIGPU FIZPM FYUFA HCIFZ HMCUK HZ~ IAO IHR IHW INH INR ITC IWAJR JSO JZLTJ KQ8 M1P M7P NQJWS O9- OK1 OVD P2P PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UDS UKHRP ~8M AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TO 8FD FR3 H94 K9. M7Z P64 7X8 |
ID | FETCH-LOGICAL-c375t-740f7202e3f5b87643d00c2545eb56cb32f40b37b01515a9789e8612521495f23 |
ISSN | 1365-7852 1476-5608 |
IngestDate | Mon Aug 25 04:31:31 EDT 2025 Sat Aug 23 12:54:32 EDT 2025 Mon Jul 21 06:04:31 EDT 2025 Tue Jul 01 03:42:16 EDT 2025 Thu Apr 24 23:10:00 EDT 2025 Mon Jul 21 06:07:58 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | 2023. The Author(s), under exclusive licence to Springer Nature Limited. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c375t-740f7202e3f5b87643d00c2545eb56cb32f40b37b01515a9789e8612521495f23 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Undefined-1 ObjectType-Review-4 content type line 23 |
ORCID | 0000-0002-7455-8803 0009-0005-0126-4731 0000-0002-9706-8516 0000-0002-2190-512X 0000-0001-5947-3206 0000-0001-7045-7725 |
PMID | 37875644 |
PQID | 3125876477 |
PQPubID | 27992 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2881711851 proquest_journals_3125876477 pubmed_primary_37875644 crossref_citationtrail_10_1038_s41391_023_00744_5 crossref_primary_10_1038_s41391_023_00744_5 springer_journals_10_1038_s41391_023_00744_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-12-01 |
PublicationDateYYYYMMDD | 2024-12-01 |
PublicationDate_xml | – month: 12 year: 2024 text: 2024-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England – name: Houndmills |
PublicationTitle | Prostate cancer and prostatic diseases |
PublicationTitleAbbrev | Prostate Cancer Prostatic Dis |
PublicationTitleAlternate | Prostate Cancer Prostatic Dis |
PublicationYear | 2024 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | MotterleGMorlaccoAZanovelloNAhmedMEZattoniFKarnesRJSurgical Strategies for Lymphocele Prevention in Minimally Invasive Radical Prostatectomy and Lymph Node Dissection: A Systematic ReviewJ Endourol2020341132010.1089/end.2019.071631797684 Dal MoroFZattoniFP.L.E.A.T.—Preventing Lymphocele Ensuring Absorption Transperitoneally: A Robotic TechniqueUrology2017110244710.1016/j.urology.2017.05.03128554519 KeskinMSArgunÖBÖbekCTufekITunaMBMourmourisPThe incidence and sequela of lymphocele formation after robot-assisted extended pelvic lymph node dissectionBJU Int20161181273110.1111/bju.1342526800257 BasourakosSPZhuALewickiPJRamaswamyAChengEDudleyVClipless Robotic-assisted Radical Prostatectomy and Impact on OutcomesEur Urol Focus2022811768510.1016/j.euf.2021.06.01034246618 EasthamJAAuffenbergGBBarocasDAChouRCrispinoTDavisJWClinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-UpJ Urol2022208192510.1097/JU.000000000000275835536148 Creta M, Manfredi C, Arcaniolo D, Spirito L, Kaplan SA, Woo HH, et al. Functional and oncological outcomes after radical prostatectomy in patients with history of surgery for lower urinary tract symptoms related to benign prostatic enlargement: A systematic review with meta-analysis. Prostate Cancer Prostatic Dis. 2023. https://doi.org/10.1038/s41391-023-00678-y BoğaMSSönmezMGKaramikKYilmazKSavaşMAteşMThe effect of peritoneal re-approximation on lymphocele formation in transperitoneal robot-assisted radical prostatectomy and extended pelvic lymphadenectomyTurk J Urol202046460710.5152/tud.2020.20255328336187608535 MaJLiuWHunterAZhangWPerforming meta-analysis with incomplete statistical information in clinical trialsBMC Med Res Methodol2008810.1186/1471-2288-8-56187061242571096 DanuserHDi PierroGBStuckiPMatteiAExtended pelvic lymphadenectomy and various radical prostatectomy techniques: Is pelvic drainage necessary?BJU Int2013111963910.1111/j.1464-410X.2012.11681.x23356829 May M, Gilfrich C, Bründl J, Ubrig B, Wagner JR, Gloger S, et al. Impact of Peritoneal Interposition Flap on Patients Undergoing Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol Focus. 2023. https://doi.org/10.1016/j.euf.2023.07.007 S2405-456900181-5. Neuberger M, Kowalewski K, Simon V, von Hardenberg J, Siegel F, Wessels F, et al. Peritoneal Flap for Lymphocele Prophylaxis Following Robotic-assisted Radical Prostatectomy with Lymph Node Dissection: The Randomised Controlled Phase 3 PELYCAN Trial. Eur Urol Oncol. 2023; https://doi.org/10.1016/j.euo.2023.07.009 S2588-931100152-9. StolzenburgJUWasserscheidJRabenaltRDoMSchwalenbergTMcNeillAReduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestrationWorld J Urol200826581610.1007/s00345-008-0327-318777125 DindoDDemartinesNClavienPAClassification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a surveyAnn Surg20042402051310.1097/01.sla.0000133083.54934.ae152735421360123 OrvietoMACoelhoRFChauhanSPalmerKJRoccoBPatelVRIncidence of lymphoceles after robot-assisted pelvic lymph node dissectionBJU Int201110811859010.1111/j.1464-410X.2011.10094.x21489117 Seetharam BhatKROnolFRogersTGanapathiHPMoschovasMRoofSCan we predict who will need lymphocele drainage following robot assisted laparoscopic prostatectomy (RALP)?J Robot Surg202014439451:STN:280:DC%2BB3MvovFKruw%3D%3D10.1007/s11701-019-01010-431422556 Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberatiet A, al. The Oxford 2011 Levels of Evidence. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence. Last access: August 12, 2023. LebeisCCanesDSorciniAMoinzadehANovel technique prevents lymphoceles after transperitoneal robotic-assisted pelvic lymph node dissection: Peritoneal flap interpositionUrology2015851505910.1016/j.urology.2015.02.03426099895 PoseRMKnipperSWürnschimmelCTennstedtPMichlUMaurerTSignificant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissectionBJU Int20211287283310.1111/bju.1549734036733 LinLChuHQuantifying publication bias in meta-analysisBiometrics2018747859410.1111/biom.1281729141096 KallappanSManickamRNachimuthuSGanesapandiTUnusual lymphocele following radical cystectomy with orthotopic neobladderIndian J Urol201935168910.4103/iju.IJU_284_18310009266458803 Masterson J, Luu M, Naser-Tavakolian A, Freedland S, Sandler H, Zumsteg Z, et al. Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer. Prostate Cancer Prostatic Dis. 2023. https://doi.org/10.1038/s41391-022-00635-1 BrigantiAChunFKHSaloniaASuardiNGallinaADa PozzoLFComplications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate CancerEur Urol20065010061310.1016/j.eururo.2006.08.01516959399 BramerWMRethlefsenMLKleijnenJFrancoOHOptimal database combinations for literature searches in systematic reviews: A prospective exploratory studySyst Rev2017610.1186/s13643-017-0644-y292080345718002 SterneJACSavovićJPageMJElbersRGBlencoweNSBoutronIRoB 2: A revised tool for assessing risk of bias in randomised trialsBMJ2019366l489810.1136/bmj.l489831462531 HarlandNAlfarraMErneEMaasMAmendBBedkeJA Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical ProstatectomyJ Clin Med20231279110.3390/jcm12030791367694409917373 HigginsJPTThompsonSGQuantifying heterogeneity in a meta-analysisStat Med20022115395810.1002/sim.118612111919 WanXWangWLiuJTongTEstimating the sample mean and standard deviation from the sample size, median, range and/or interquartile rangeBMC Med Res Methodol20141410.1186/1471-2288-14-135255244434383202 LeeMLeeZEunDDUtilization of a Peritoneal Interposition Flap to Prevent Symptomatic Lymphoceles after Robotic Radical Prostatectomy and Bilateral Pelvic Lymph Node DissectionJ Endourol202034821710.1089/end.2020.007332303137 GlogerSUbrigBBoyALeyh-BannurahSRSiemerSArndtMBilateral Peritoneal Flaps Reduce Incidence and Complications of Lymphoceles after Robotic Radical Prostatectomy with Pelvic Lymph Node Dissection - Results of the Prospective Randomized Multicenter Trial ProLyJ Urol20222083334010.1097/JU.0000000000002693354221369275839 CapitanioUPellucchiFGallinaABrigantiASuardiNSaloniaAHow can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implicationsBJU Int2011107109510110.1111/j.1464-410X.2010.09580.x20880192 GrandePDi PierroGBMordasiniLFerrariMWürnschimmelCDanuserHProspective Randomized Trial Comparing Titanium Clips to Bipolar Coagulation in Sealing Lymphatic Vessels During Pelvic Lymph Node Dissection at the Time of Robot-assisted Radical ProstatectomyEur Urol201771155810.1016/j.eururo.2016.08.00627544575 Amir-BehghadamiMJanatiAPopulation, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviewsEmerg Med J20203738710.1136/emermed-2020-20956732253195 Mottet N, Cornford P, Van den Bergh R, Eberli D, De Meerleer G, De Santis M, et al. EAU Guidelines on Prostate Cancer. Edn presented at the EAU Annual Congress Milan. 2023. ISBN 978-94-92671-19-6 FioriCCheccucciESturaIAmparoreDDe CillisSPianaADevelopment of a novel nomogram to identify the candidate to extended pelvic lymph node dissection in patients who underwent mpMRI and target biopsy onlyProstate Cancer Prostatic Dis2023263889410.1038/s41391-022-00565-y35750851 StudentVTudosZStudentovaZCesakOStudentovaHRepaVEffect of Peritoneal Fixation (PerFix) on Lymphocele Formation in Robot-assisted Radical Prostatectomy with Pelvic Lymphadenectomy: Results of a Randomized Prospective TrialEur Urol2023831546210.1016/j.eururo.2022.07.02736041934 WagnerJMcLaughlinTPintoKTortoraJGangakhedkarAStaffIThe Effect of a Peritoneal Iliac Flap on Lymphocele Formation After Robotic Radical Prostatectomy: Results From the PLUS TrialUrology20231731041010.1016/j.urology.2022.12.00236549574 BründlJLenartSStojanoskiGGilfrichCRosenhammerBStolzlechnerMPeritoneal flap in robot-assisted radical prostatectomy: Results of a multicenter, randomized, single-blind study (PIANOFORTE) of the efficacy in reducing postoperative lymphoceleDtsch Arztebl Int202011724350324498967264288 PageMJMcKenzieJEBossuytPMBoutronIHoffmannTCMulrowCDThe PRISMA 2020 statement: An updated guideline for reporting systematic reviewsBMJ2021372n7110.1136/bmj.n71337820578005924 YılmazKÖlçücüMTArıÖKaramikKAktaşYSavaşMThe Results of Peritoneal Re-Approximation Methods on Symptomatic Lymphocele Formation in Robot-Assisted Laparoscopic Radical Prostatectomy and Extended Pelvic LymphadenectomyArch Esp Urol2022754475210.56434/j.arch.esp.urol.20227505.6535983817 SterneJAHernánMAReevesBCSavovićJBerkmanNDViswanathanMROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventionsBMJ2016355i491910.1136/bmj.i4919277333545062054 WaldertMRemziMKlatteTKlinglerHCFloseal reduces the incidence of lymphoceles after lymphadenectomies in laparoscopic and robot-assisted extraperitoneal radical prostatectomyJ Endourol2011259697310.1089/end.2010.063521542773 NaselliAAndreattaRIntroiniCFontanaVPuppoPPredictors of Symptomatic Lymphocele After Lymph Node Excision and Radical ProstatectomyUrology201075630510.1016/j.urology.2009.03.01119476977 TerritoABaboudjianMDianaPGallioliAVerriPUleriATo drain or not to drain in uro-oncological robotic surgery? A systematic review and meta-analysisMinerva Urol Nephrol2023751445310.23736/S2724-6051.22.05160-636722161 P Grande (744_CR13) 2017; 71 M Amir-Behghadami (744_CR20) 2020; 37 744_CR25 N Harland (744_CR31) 2023; 12 M Lee (744_CR34) 2020; 34 A Naselli (744_CR11) 2010; 75 J Bründl (744_CR17) 2020; 117 MS Keskin (744_CR8) 2016; 118 D Dindo (744_CR22) 2004; 240 M Waldert (744_CR12) 2011; 25 S Gloger (744_CR32) 2022; 208 JA Eastham (744_CR2) 2022; 208 JPT Higgins (744_CR28) 2002; 21 MJ Page (744_CR18) 2021; 372 RM Pose (744_CR36) 2021; 128 744_CR43 X Wan (744_CR26) 2014; 14 J Wagner (744_CR30) 2023; 173 KR Seetharam Bhat (744_CR42) 2020; 14 C Fiori (744_CR3) 2023; 26 V Student (744_CR15) 2023; 83 JA Sterne (744_CR24) 2016; 355 MA Orvieto (744_CR7) 2011; 108 J Ma (744_CR27) 2008; 8 744_CR1 C Lebeis (744_CR9) 2015; 85 744_CR5 744_CR4 G Motterle (744_CR21) 2020; 34 744_CR16 JU Stolzenburg (744_CR10) 2008; 26 MS Boğa (744_CR33) 2020; 46 F Dal Moro (744_CR35) 2017; 110 WM Bramer (744_CR19) 2017; 6 A Territo (744_CR40) 2023; 75 K Yılmaz (744_CR14) 2022; 75 S Kallappan (744_CR37) 2019; 35 H Danuser (744_CR39) 2013; 111 U Capitanio (744_CR41) 2011; 107 A Briganti (744_CR6) 2006; 50 SP Basourakos (744_CR38) 2022; 8 JAC Sterne (744_CR23) 2019; 366 L Lin (744_CR29) 2018; 74 |
References_xml | – reference: PoseRMKnipperSWürnschimmelCTennstedtPMichlUMaurerTSignificant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissectionBJU Int20211287283310.1111/bju.1549734036733 – reference: Creta M, Manfredi C, Arcaniolo D, Spirito L, Kaplan SA, Woo HH, et al. Functional and oncological outcomes after radical prostatectomy in patients with history of surgery for lower urinary tract symptoms related to benign prostatic enlargement: A systematic review with meta-analysis. Prostate Cancer Prostatic Dis. 2023. https://doi.org/10.1038/s41391-023-00678-y – reference: Seetharam BhatKROnolFRogersTGanapathiHPMoschovasMRoofSCan we predict who will need lymphocele drainage following robot assisted laparoscopic prostatectomy (RALP)?J Robot Surg202014439451:STN:280:DC%2BB3MvovFKruw%3D%3D10.1007/s11701-019-01010-431422556 – reference: WagnerJMcLaughlinTPintoKTortoraJGangakhedkarAStaffIThe Effect of a Peritoneal Iliac Flap on Lymphocele Formation After Robotic Radical Prostatectomy: Results From the PLUS TrialUrology20231731041010.1016/j.urology.2022.12.00236549574 – reference: CapitanioUPellucchiFGallinaABrigantiASuardiNSaloniaAHow can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implicationsBJU Int2011107109510110.1111/j.1464-410X.2010.09580.x20880192 – reference: MaJLiuWHunterAZhangWPerforming meta-analysis with incomplete statistical information in clinical trialsBMC Med Res Methodol2008810.1186/1471-2288-8-56187061242571096 – reference: HigginsJPTThompsonSGQuantifying heterogeneity in a meta-analysisStat Med20022115395810.1002/sim.118612111919 – reference: SterneJACSavovićJPageMJElbersRGBlencoweNSBoutronIRoB 2: A revised tool for assessing risk of bias in randomised trialsBMJ2019366l489810.1136/bmj.l489831462531 – reference: SterneJAHernánMAReevesBCSavovićJBerkmanNDViswanathanMROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventionsBMJ2016355i491910.1136/bmj.i4919277333545062054 – reference: KallappanSManickamRNachimuthuSGanesapandiTUnusual lymphocele following radical cystectomy with orthotopic neobladderIndian J Urol201935168910.4103/iju.IJU_284_18310009266458803 – reference: EasthamJAAuffenbergGBBarocasDAChouRCrispinoTDavisJWClinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-UpJ Urol2022208192510.1097/JU.000000000000275835536148 – reference: LebeisCCanesDSorciniAMoinzadehANovel technique prevents lymphoceles after transperitoneal robotic-assisted pelvic lymph node dissection: Peritoneal flap interpositionUrology2015851505910.1016/j.urology.2015.02.03426099895 – reference: WanXWangWLiuJTongTEstimating the sample mean and standard deviation from the sample size, median, range and/or interquartile rangeBMC Med Res Methodol20141410.1186/1471-2288-14-135255244434383202 – reference: WaldertMRemziMKlatteTKlinglerHCFloseal reduces the incidence of lymphoceles after lymphadenectomies in laparoscopic and robot-assisted extraperitoneal radical prostatectomyJ Endourol2011259697310.1089/end.2010.063521542773 – reference: PageMJMcKenzieJEBossuytPMBoutronIHoffmannTCMulrowCDThe PRISMA 2020 statement: An updated guideline for reporting systematic reviewsBMJ2021372n7110.1136/bmj.n71337820578005924 – reference: BasourakosSPZhuALewickiPJRamaswamyAChengEDudleyVClipless Robotic-assisted Radical Prostatectomy and Impact on OutcomesEur Urol Focus2022811768510.1016/j.euf.2021.06.01034246618 – reference: TerritoABaboudjianMDianaPGallioliAVerriPUleriATo drain or not to drain in uro-oncological robotic surgery? A systematic review and meta-analysisMinerva Urol Nephrol2023751445310.23736/S2724-6051.22.05160-636722161 – reference: Mottet N, Cornford P, Van den Bergh R, Eberli D, De Meerleer G, De Santis M, et al. EAU Guidelines on Prostate Cancer. Edn presented at the EAU Annual Congress Milan. 2023. ISBN 978-94-92671-19-6 – reference: MotterleGMorlaccoAZanovelloNAhmedMEZattoniFKarnesRJSurgical Strategies for Lymphocele Prevention in Minimally Invasive Radical Prostatectomy and Lymph Node Dissection: A Systematic ReviewJ Endourol2020341132010.1089/end.2019.071631797684 – reference: DindoDDemartinesNClavienPAClassification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a surveyAnn Surg20042402051310.1097/01.sla.0000133083.54934.ae152735421360123 – reference: Dal MoroFZattoniFP.L.E.A.T.—Preventing Lymphocele Ensuring Absorption Transperitoneally: A Robotic TechniqueUrology2017110244710.1016/j.urology.2017.05.03128554519 – reference: BründlJLenartSStojanoskiGGilfrichCRosenhammerBStolzlechnerMPeritoneal flap in robot-assisted radical prostatectomy: Results of a multicenter, randomized, single-blind study (PIANOFORTE) of the efficacy in reducing postoperative lymphoceleDtsch Arztebl Int202011724350324498967264288 – reference: Masterson J, Luu M, Naser-Tavakolian A, Freedland S, Sandler H, Zumsteg Z, et al. Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer. Prostate Cancer Prostatic Dis. 2023. https://doi.org/10.1038/s41391-022-00635-1 – reference: NaselliAAndreattaRIntroiniCFontanaVPuppoPPredictors of Symptomatic Lymphocele After Lymph Node Excision and Radical ProstatectomyUrology201075630510.1016/j.urology.2009.03.01119476977 – reference: BrigantiAChunFKHSaloniaASuardiNGallinaADa PozzoLFComplications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate CancerEur Urol20065010061310.1016/j.eururo.2006.08.01516959399 – reference: KeskinMSArgunÖBÖbekCTufekITunaMBMourmourisPThe incidence and sequela of lymphocele formation after robot-assisted extended pelvic lymph node dissectionBJU Int20161181273110.1111/bju.1342526800257 – reference: StudentVTudosZStudentovaZCesakOStudentovaHRepaVEffect of Peritoneal Fixation (PerFix) on Lymphocele Formation in Robot-assisted Radical Prostatectomy with Pelvic Lymphadenectomy: Results of a Randomized Prospective TrialEur Urol2023831546210.1016/j.eururo.2022.07.02736041934 – reference: May M, Gilfrich C, Bründl J, Ubrig B, Wagner JR, Gloger S, et al. Impact of Peritoneal Interposition Flap on Patients Undergoing Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol Focus. 2023. https://doi.org/10.1016/j.euf.2023.07.007 S2405-456900181-5. – reference: StolzenburgJUWasserscheidJRabenaltRDoMSchwalenbergTMcNeillAReduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestrationWorld J Urol200826581610.1007/s00345-008-0327-318777125 – reference: YılmazKÖlçücüMTArıÖKaramikKAktaşYSavaşMThe Results of Peritoneal Re-Approximation Methods on Symptomatic Lymphocele Formation in Robot-Assisted Laparoscopic Radical Prostatectomy and Extended Pelvic LymphadenectomyArch Esp Urol2022754475210.56434/j.arch.esp.urol.20227505.6535983817 – reference: LinLChuHQuantifying publication bias in meta-analysisBiometrics2018747859410.1111/biom.1281729141096 – reference: HarlandNAlfarraMErneEMaasMAmendBBedkeJA Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical ProstatectomyJ Clin Med20231279110.3390/jcm12030791367694409917373 – reference: BoğaMSSönmezMGKaramikKYilmazKSavaşMAteşMThe effect of peritoneal re-approximation on lymphocele formation in transperitoneal robot-assisted radical prostatectomy and extended pelvic lymphadenectomyTurk J Urol202046460710.5152/tud.2020.20255328336187608535 – reference: LeeMLeeZEunDDUtilization of a Peritoneal Interposition Flap to Prevent Symptomatic Lymphoceles after Robotic Radical Prostatectomy and Bilateral Pelvic Lymph Node DissectionJ Endourol202034821710.1089/end.2020.007332303137 – reference: Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberatiet A, al. The Oxford 2011 Levels of Evidence. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence. Last access: August 12, 2023. – reference: FioriCCheccucciESturaIAmparoreDDe CillisSPianaADevelopment of a novel nomogram to identify the candidate to extended pelvic lymph node dissection in patients who underwent mpMRI and target biopsy onlyProstate Cancer Prostatic Dis2023263889410.1038/s41391-022-00565-y35750851 – reference: OrvietoMACoelhoRFChauhanSPalmerKJRoccoBPatelVRIncidence of lymphoceles after robot-assisted pelvic lymph node dissectionBJU Int201110811859010.1111/j.1464-410X.2011.10094.x21489117 – reference: BramerWMRethlefsenMLKleijnenJFrancoOHOptimal database combinations for literature searches in systematic reviews: A prospective exploratory studySyst Rev2017610.1186/s13643-017-0644-y292080345718002 – reference: GlogerSUbrigBBoyALeyh-BannurahSRSiemerSArndtMBilateral Peritoneal Flaps Reduce Incidence and Complications of Lymphoceles after Robotic Radical Prostatectomy with Pelvic Lymph Node Dissection - Results of the Prospective Randomized Multicenter Trial ProLyJ Urol20222083334010.1097/JU.0000000000002693354221369275839 – reference: DanuserHDi PierroGBStuckiPMatteiAExtended pelvic lymphadenectomy and various radical prostatectomy techniques: Is pelvic drainage necessary?BJU Int2013111963910.1111/j.1464-410X.2012.11681.x23356829 – reference: GrandePDi PierroGBMordasiniLFerrariMWürnschimmelCDanuserHProspective Randomized Trial Comparing Titanium Clips to Bipolar Coagulation in Sealing Lymphatic Vessels During Pelvic Lymph Node Dissection at the Time of Robot-assisted Radical ProstatectomyEur Urol201771155810.1016/j.eururo.2016.08.00627544575 – reference: Neuberger M, Kowalewski K, Simon V, von Hardenberg J, Siegel F, Wessels F, et al. Peritoneal Flap for Lymphocele Prophylaxis Following Robotic-assisted Radical Prostatectomy with Lymph Node Dissection: The Randomised Controlled Phase 3 PELYCAN Trial. Eur Urol Oncol. 2023; https://doi.org/10.1016/j.euo.2023.07.009 S2588-931100152-9. – reference: Amir-BehghadamiMJanatiAPopulation, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviewsEmerg Med J20203738710.1136/emermed-2020-20956732253195 – volume: 85 start-page: 1505 year: 2015 ident: 744_CR9 publication-title: Urology doi: 10.1016/j.urology.2015.02.034 – volume: 75 start-page: 447 year: 2022 ident: 744_CR14 publication-title: Arch Esp Urol doi: 10.56434/j.arch.esp.urol.20227505.65 – volume: 173 start-page: 104 year: 2023 ident: 744_CR30 publication-title: Urology doi: 10.1016/j.urology.2022.12.002 – volume: 75 start-page: 144 year: 2023 ident: 744_CR40 publication-title: Minerva Urol Nephrol doi: 10.23736/S2724-6051.22.05160-6 – volume: 34 start-page: 113 year: 2020 ident: 744_CR21 publication-title: J Endourol doi: 10.1089/end.2019.0716 – ident: 744_CR5 doi: 10.1038/s41391-023-00678-y – volume: 75 start-page: 630 year: 2010 ident: 744_CR11 publication-title: Urology doi: 10.1016/j.urology.2009.03.011 – volume: 118 start-page: 127 year: 2016 ident: 744_CR8 publication-title: BJU Int doi: 10.1111/bju.13425 – volume: 14 year: 2014 ident: 744_CR26 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-14-135 – volume: 108 start-page: 1185 year: 2011 ident: 744_CR7 publication-title: BJU Int doi: 10.1111/j.1464-410X.2011.10094.x – volume: 83 start-page: 154 year: 2023 ident: 744_CR15 publication-title: Eur Urol doi: 10.1016/j.eururo.2022.07.027 – volume: 35 start-page: 168 year: 2019 ident: 744_CR37 publication-title: Indian J Urol doi: 10.4103/iju.IJU_284_18 – ident: 744_CR16 doi: 10.1016/j.euo.2023.07.009 – volume: 117 start-page: 243 year: 2020 ident: 744_CR17 publication-title: Dtsch Arztebl Int – volume: 111 start-page: 963 year: 2013 ident: 744_CR39 publication-title: BJU Int doi: 10.1111/j.1464-410X.2012.11681.x – volume: 110 start-page: 244 year: 2017 ident: 744_CR35 publication-title: Urology doi: 10.1016/j.urology.2017.05.031 – volume: 50 start-page: 1006 year: 2006 ident: 744_CR6 publication-title: Eur Urol doi: 10.1016/j.eururo.2006.08.015 – volume: 372 start-page: n71 year: 2021 ident: 744_CR18 publication-title: BMJ doi: 10.1136/bmj.n71 – volume: 71 start-page: 155 year: 2017 ident: 744_CR13 publication-title: Eur Urol doi: 10.1016/j.eururo.2016.08.006 – volume: 14 start-page: 439 year: 2020 ident: 744_CR42 publication-title: J Robot Surg doi: 10.1007/s11701-019-01010-4 – volume: 8 year: 2008 ident: 744_CR27 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-8-56 – volume: 128 start-page: 728 year: 2021 ident: 744_CR36 publication-title: BJU Int doi: 10.1111/bju.15497 – volume: 240 start-page: 205 year: 2004 ident: 744_CR22 publication-title: Ann Surg doi: 10.1097/01.sla.0000133083.54934.ae – volume: 74 start-page: 785 year: 2018 ident: 744_CR29 publication-title: Biometrics doi: 10.1111/biom.12817 – ident: 744_CR25 – volume: 34 start-page: 821 year: 2020 ident: 744_CR34 publication-title: J Endourol doi: 10.1089/end.2020.0073 – volume: 208 start-page: 333 year: 2022 ident: 744_CR32 publication-title: J Urol doi: 10.1097/JU.0000000000002693 – volume: 6 year: 2017 ident: 744_CR19 publication-title: Syst Rev doi: 10.1186/s13643-017-0644-y – volume: 208 start-page: 19 year: 2022 ident: 744_CR2 publication-title: J Urol doi: 10.1097/JU.0000000000002758 – volume: 26 start-page: 388 year: 2023 ident: 744_CR3 publication-title: Prostate Cancer Prostatic Dis doi: 10.1038/s41391-022-00565-y – volume: 21 start-page: 1539 year: 2002 ident: 744_CR28 publication-title: Stat Med doi: 10.1002/sim.1186 – volume: 12 start-page: 791 year: 2023 ident: 744_CR31 publication-title: J Clin Med doi: 10.3390/jcm12030791 – volume: 46 start-page: 460 year: 2020 ident: 744_CR33 publication-title: Turk J Urol doi: 10.5152/tud.2020.20255 – ident: 744_CR1 – volume: 26 start-page: 581 year: 2008 ident: 744_CR10 publication-title: World J Urol doi: 10.1007/s00345-008-0327-3 – ident: 744_CR4 doi: 10.1038/s41391-022-00635-1 – volume: 25 start-page: 969 year: 2011 ident: 744_CR12 publication-title: J Endourol doi: 10.1089/end.2010.0635 – volume: 37 start-page: 387 year: 2020 ident: 744_CR20 publication-title: Emerg Med J doi: 10.1136/emermed-2020-209567 – volume: 366 start-page: l4898 year: 2019 ident: 744_CR23 publication-title: BMJ doi: 10.1136/bmj.l4898 – volume: 107 start-page: 1095 year: 2011 ident: 744_CR41 publication-title: BJU Int doi: 10.1111/j.1464-410X.2010.09580.x – volume: 8 start-page: 1176 year: 2022 ident: 744_CR38 publication-title: Eur Urol Focus doi: 10.1016/j.euf.2021.06.010 – ident: 744_CR43 doi: 10.1016/j.euf.2023.07.007 – volume: 355 start-page: i4919 year: 2016 ident: 744_CR24 publication-title: BMJ doi: 10.1136/bmj.i4919 |
SSID | ssj0009190 |
Score | 2.4131138 |
SecondaryResourceType | review_article |
Snippet | Background
Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection... Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND).... BackgroundDifferent strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 635 |
SubjectTerms | 692/308/409 692/699/67/1059 692/699/67/589/466 Biomedical and Life Sciences Biomedicine Cancer Research Clinical outcomes Clinical trials Dissection Humans Impact analysis Lymph Node Excision - adverse effects Lymph Node Excision - methods Lymph nodes Lymphatic system Lymphocele Lymphocele - epidemiology Lymphocele - etiology Lymphocele - prevention & control Male Meta-analysis Pelvis - pathology Pelvis - surgery Peritoneum Peritoneum - pathology Peritoneum - surgery Postoperative Complications - epidemiology Postoperative Complications - etiology Postoperative Complications - prevention & control Prostate cancer Prostatectomy Prostatectomy - adverse effects Prostatectomy - methods Prostatic Neoplasms - pathology Prostatic Neoplasms - surgery Randomized Controlled Trials as Topic Reconfiguration Reproductive Medicine Review Article Robotic surgery Robotic Surgical Procedures - adverse effects Robotic Surgical Procedures - methods Side effects Systematic review |
Title | Impact of peritoneal reconfiguration on lymphocele formation after robot-assisted radical prostatectomy with pelvic lymph node dissection: a systematic review and meta-analysis of randomized controlled trials |
URI | https://link.springer.com/article/10.1038/s41391-023-00744-5 https://www.ncbi.nlm.nih.gov/pubmed/37875644 https://www.proquest.com/docview/3125876477 https://www.proquest.com/docview/2881711851 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb5wwELbykKpeqr67bVo5Um9bp2AbDL1t2kZppUQ9JFVuyICJIrHLapc9JL-yP6njB5jNNlVTCSFkYDDMh2fGHn9G6L2SSQWeaEryhHHCKxmQPBU5YaUIeSSTIDV9uien8fE5_34RXWxt7w-yllZtflDc_HFeyf9oFcpAr3qW7D002wuFAjgG_cIeNAz7f9Lxt36Ko-Yr1rTahqYfQtzq6nLldAtbfQ06A0NVKz9Z0a0OvmjypiXgQWt1l-OFtOM2cz0ZROoBhmZ6bTtr56qGVsXKGs-aUo3NWH7RZYfIDVZom2w8Va0kcsB9AtaxbKZXN6rsEuVrODTLhyyHvvIPVwedmFaohaM0MGXwBDey1IcEX_T7m3XE7WIhalk0vrt9Vi3ASpteYfgKy7aHs7m2cTQK0L719_wE1NlE4kmtl4nRxA7DLhLKB-kmtlXXqXwisVS5B8qWcRETcPeSoSmwNAUO8nzQrseWU8W5CLGlrNywPpZrfgl-gU4no4xoB42TyNvaLr_glgnuEyNNSgBLMisjAxmZkZFF22iXQiQETfnu5Ojw8NQzS4dp0E0u1O_oZoaBlI-bNVn3vjZCqo10AONlnT1Gj1x4hCcW60_Qlpo9RQ9OXALIM_TLQh43FfaQx7cgj2HzkMc95LGBPF6HPHaQx2uQxxry2ELeysIa8thD_hOW2AMeW8BjgAleA7yuqQc89oDHFvDP0fnR17PPx8QtSkIKJqKWCB5UAkCmWBXl4EpwVgZBQSEQUXkUFzmjFQ9yJvJAhwoyFUmqEh1GUN0XUVH2Au3M4OO8QjhJqeQxlTEPC664kAVPyyCUQVmFMqV0hMJOWVnhGPv1wjF1djdMRmjc3zO3fDV_vXqvw0Dm2rVlxqCy-sWEGKH9_jRYHT2UKGeqWS0zmiShCMHXD0fopcVO_zgGPkAEv8gIfejA5IXfXZfX96r5G_TQ_-l7aKddrNRbCA_a_J37QX4DXgoWnA |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+peritoneal+reconfiguration+on+lymphocele+formation+after+robot-assisted+radical+prostatectomy+with+pelvic+lymph+node+dissection%3A+a+systematic+review+and+meta-analysis+of+randomized+controlled+trials&rft.jtitle=Prostate+cancer+and+prostatic+diseases&rft.au=Ditonno%2C+Francesco&rft.au=Manfredi%2C+Celeste&rft.au=Franco%2C+Antonio&rft.au=Veccia%2C+Alessandro&rft.date=2024-12-01&rft.issn=1365-7852&rft.eissn=1476-5608&rft.volume=27&rft.issue=4&rft.spage=635&rft.epage=644&rft_id=info:doi/10.1038%2Fs41391-023-00744-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41391_023_00744_5 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1365-7852&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1365-7852&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1365-7852&client=summon |